CN103751674A - Traditional Chinese medicinal decoction for treating bronchial asthma - Google Patents
Traditional Chinese medicinal decoction for treating bronchial asthma Download PDFInfo
- Publication number
- CN103751674A CN103751674A CN201410030619.7A CN201410030619A CN103751674A CN 103751674 A CN103751674 A CN 103751674A CN 201410030619 A CN201410030619 A CN 201410030619A CN 103751674 A CN103751674 A CN 103751674A
- Authority
- CN
- China
- Prior art keywords
- asthma
- rhizoma
- bronchial asthma
- traditional chinese
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006673 Asthma Diseases 0.000 title claims abstract description 28
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 6
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 238000002791 soaking Methods 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 19
- 229940079593 drugs Drugs 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 240000001312 Pecteilis susannae Species 0.000 claims description 5
- 241001148662 Phragmites australis Species 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 210000004072 Lung Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 16
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 9
- 201000010874 syndrome Diseases 0.000 abstract description 4
- 231100000486 side effect Toxicity 0.000 abstract description 2
- 230000001225 therapeutic Effects 0.000 abstract description 2
- 210000003165 Abomasum Anatomy 0.000 abstract 1
- 241001573366 Astragalus membranaceus Species 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 240000008564 Boehmeria nivea Species 0.000 abstract 1
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 240000000661 Kaempferia galanga Species 0.000 abstract 1
- 241000382298 Lagotis Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241001633680 Polygonatum odoratum Species 0.000 abstract 1
- 241000220262 Sinapis alba Species 0.000 abstract 1
- 241000001522 Terminalia chebula Species 0.000 abstract 1
- 235000011517 Terminalia chebula Nutrition 0.000 abstract 1
- 241001643425 Tinospora sinensis Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 10
- 210000004369 Blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 230000014860 sensory perception of taste Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 230000035917 taste Effects 0.000 description 7
- 230000001737 promoting Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000001717 pathogenic Effects 0.000 description 5
- 230000002522 swelling Effects 0.000 description 5
- 210000001124 Body Fluids Anatomy 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010022114 Injury Diseases 0.000 description 4
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-1 atom-0' d='M 181.5,168.6 L 171.5,173.3 L 173.5,176.2 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-0 atom-1 atom-0' d='M 171.5,173.3 L 165.5,183.8 L 161.6,178.1 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-0 atom-1 atom-0' d='M 171.5,173.3 L 173.5,176.2 L 165.5,183.8 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-11 atom-12 atom-0' d='M 125.9,176.6 L 126.7,175.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-0' d='M 130.6,179.8 L 132.1,176.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-0' d='M 135.3,183.0 L 137.5,178.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-0' d='M 139.9,186.2 L 142.9,179.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 181.5,168.6 L 213.0,183.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-9 atom-1' d='M 178.6,133.8 L 181.5,168.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 213.0,183.5 L 212.2,195.0 L 215.6,194.7 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 212.2,195.0 L 218.3,206.0 L 211.3,206.5 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 212.2,195.0 L 215.6,194.7 L 218.3,206.0 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-3 atom-2 atom-4' d='M 213.0,183.5 L 241.7,163.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 246.3,166.9 L 247.1,165.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 251.0,170.0 L 252.5,166.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 255.6,173.2 L 257.9,168.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 260.3,176.4 L 263.3,170.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-4 atom-6' d='M 241.7,163.7 L 238.8,128.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 238.8,128.9 L 248.8,124.2 L 246.8,121.3 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-6 atom-6 atom-7' d='M 248.8,124.2 L 254.7,113.7 L 258.7,119.4 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-6 atom-6 atom-7' d='M 248.8,124.2 L 246.8,121.3 L 254.7,113.7 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-7 atom-6 atom-8' d='M 238.8,128.9 L 228.8,124.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-6 atom-8' d='M 228.8,124.2 L 218.7,119.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 196.5,121.5 L 187.6,127.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 187.6,127.6 L 178.6,133.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 173.6,130.8 L 173.1,131.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 168.6,127.8 L 167.6,129.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 163.6,124.8 L 162.1,127.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 158.6,121.8 L 156.6,126.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 153.6,118.7 L 151.1,124.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 148.6,115.7 L 145.6,122.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 147.1,118.9 L 146.3,108.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 146.3,108.9 L 145.5,98.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 121.3,173.4 L 92.6,193.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-22 atom-12' d='M 119.6,153.5 L 120.5,163.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-22 atom-12' d='M 120.5,163.5 L 121.3,173.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 92.2,199.0 L 93.9,198.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 91.8,204.8 L 95.2,204.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 91.4,210.5 L 96.6,210.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 91.0,216.3 L 97.9,215.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 92.6,193.3 L 61.1,178.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 61.1,178.3 L 51.1,183.1 L 53.1,185.9 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-15 atom-15 atom-16' d='M 51.1,183.1 L 45.2,193.6 L 41.2,187.8 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-15 atom-15 atom-16' d='M 51.1,183.1 L 53.1,185.9 L 45.2,193.6 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-16 atom-15 atom-17' d='M 61.1,178.3 L 58.3,143.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 58.3,143.6 L 48.9,137.2 L 47.4,140.4 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-17 atom-17 atom-18' d='M 48.9,137.2 L 36.6,137.2 L 39.6,130.9 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-17 atom-17 atom-18' d='M 48.9,137.2 L 47.4,140.4 L 36.6,137.2 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-18 atom-17 atom-19' d='M 58.3,143.6 L 86.9,123.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 86.9,123.8 L 87.6,88.7 L 80.6,89.3 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-21 atom-19 atom-22' d='M 86.9,123.8 L 97.0,128.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-19 atom-22' d='M 97.0,128.5 L 107.1,133.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 84.1,89.0 L 93.1,82.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 93.1,82.8 L 102.0,76.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='148.6' y='195.4' class='atom-0' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='211.6' y='225.2' class='atom-3' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='221.2' y='225.2' class='atom-3' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='269.0' y='185.6' class='atom-5' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='278.6' y='185.6' class='atom-5' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='263.3' y='116.1' class='atom-7' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='273.0' y='116.1' class='atom-7' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='203.1' y='121.0' class='atom-8' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='140.1' y='91.1' class='atom-11' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='149.8' y='91.1' class='atom-11' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='91.2' y='235.0' class='atom-14' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='100.8' y='235.0' class='atom-14' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='19.3' y='205.1' class='atom-16' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='28.2' y='205.1' class='atom-16' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='13.6' y='135.6' class='atom-18' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='22.6' y='135.6' class='atom-18' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='108.6' y='76.2' class='atom-21' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='118.3' y='76.2' class='atom-21' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='114.3' y='145.7' class='atom-22' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-1 atom-0' d='M 50.5,46.9 L 47.4,48.5 L 47.9,49.3 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-0 atom-1 atom-0' d='M 47.4,48.5 L 45.3,51.6 L 44.2,50.1 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-0 atom-1 atom-0' d='M 47.4,48.5 L 47.9,49.3 L 45.3,51.6 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-11 atom-12 atom-0' d='M 36.2,49.5 L 36.5,49.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-0' d='M 38.3,50.8 L 38.8,49.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-12 atom-0' d='M 40.3,52.2 L 41.1,50.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 50.5,46.9 L 59.1,50.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-9 atom-1' d='M 49.8,37.4 L 50.5,46.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 59.1,50.9 L 58.9,54.7 L 59.9,54.6 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 58.9,54.7 L 60.7,58.3 L 58.8,58.4 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-2 atom-2 atom-3' d='M 58.9,54.7 L 59.9,54.6 L 60.7,58.3 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-3 atom-2 atom-4' d='M 59.1,50.9 L 66.9,45.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 69.0,46.9 L 69.2,46.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 71.0,48.2 L 71.5,47.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 73.0,49.5 L 73.9,47.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-4 atom-6' d='M 66.9,45.6 L 66.1,36.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 66.1,36.1 L 69.3,34.5 L 68.8,33.7 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-6 atom-6 atom-7' d='M 69.3,34.5 L 71.4,31.3 L 72.5,32.9 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-6 atom-6 atom-7' d='M 69.3,34.5 L 68.8,33.7 L 71.4,31.3 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-7 atom-6 atom-8' d='M 66.1,36.1 L 62.9,34.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-6 atom-8' d='M 62.9,34.6 L 59.6,33.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 55.5,33.5 L 52.7,35.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 52.7,35.4 L 49.8,37.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 47.1,35.8 L 46.8,36.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 44.3,34.2 L 43.8,35.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 41.6,32.5 L 40.8,34.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 41.2,33.4 L 41.0,30.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 41.0,30.3 L 40.7,27.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 34.2,48.2 L 26.4,53.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-22 atom-12' d='M 33.7,42.0 L 33.9,45.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-22 atom-12' d='M 33.9,45.1 L 34.2,48.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 26.3,56.1 L 26.9,56.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 26.2,58.6 L 27.4,58.5' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 26.0,61.1 L 27.9,60.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-13 atom-15' d='M 26.4,53.6 L 17.8,49.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 17.8,49.5 L 14.7,51.1 L 15.2,51.9 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-15 atom-15 atom-16' d='M 14.7,51.1 L 12.6,54.3 L 11.5,52.7 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-15 atom-15 atom-16' d='M 14.7,51.1 L 15.2,51.9 L 12.6,54.3 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-16 atom-15 atom-17' d='M 17.8,49.5 L 17.0,40.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 17.0,40.1 L 14.0,38.1 L 13.6,39.0 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-17 atom-17 atom-18' d='M 14.0,38.1 L 10.1,37.9 L 10.9,36.1 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-17 atom-17 atom-18' d='M 14.0,38.1 L 13.6,39.0 L 10.1,37.9 Z' style='fill:#E84235;fill-rule:evenodd;fill-opacity:1;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-18 atom-17 atom-19' d='M 17.0,40.1 L 24.8,34.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 24.8,34.7 L 25.0,25.2 L 23.1,25.3 Z' style='fill:#3B4143;fill-rule:evenodd;fill-opacity:1;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
<path class='bond-21 atom-19 atom-22' d='M 24.8,34.7 L 28.1,36.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-19 atom-22' d='M 28.1,36.2 L 31.4,37.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 24.1,25.3 L 27.0,23.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 27.0,23.3 L 29.8,21.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='40.9' y='55.3' class='atom-0' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='58.1' y='63.4' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='62.2' y='63.4' class='atom-3' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='73.7' y='52.6' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='77.8' y='52.6' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='72.1' y='33.7' class='atom-7' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='76.3' y='33.7' class='atom-7' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='55.8' y='35.0' class='atom-8' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='38.6' y='26.9' class='atom-11' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='42.8' y='26.9' class='atom-11' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='25.3' y='66.0' class='atom-14' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='29.5' y='66.0' class='atom-14' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='4.4' y='57.9' class='atom-16' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='8.2' y='57.9' class='atom-16' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='2.8' y='39.0' class='atom-18' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='6.7' y='39.0' class='atom-18' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='30.1' y='22.9' class='atom-21' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='34.2' y='22.9' class='atom-21' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='31.6' y='41.8' class='atom-22' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000001684 chronic Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000003203 everyday Effects 0.000 description 4
- 230000025627 positive regulation of urine volume Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000002173 Dizziness Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 210000003205 Muscles Anatomy 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000001154 acute Effects 0.000 description 3
- 230000003419 expectorant Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 230000002588 toxic Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 206010018836 Haematochezia Diseases 0.000 description 2
- 206010018987 Haemorrhage Diseases 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000002435 Tendons Anatomy 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 231100000319 bleeding Toxicity 0.000 description 2
- 230000000740 bleeding Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001605 fetal Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000414 obstructive Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 230000002685 pulmonary Effects 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000210 Abortion Diseases 0.000 description 1
- 206010000269 Abscess Diseases 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000001780 Epistaxis Diseases 0.000 description 1
- 206010016286 Febrile disease Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000009856 Lung Disease Diseases 0.000 description 1
- 210000002264 Mammary Glands, Animal Anatomy 0.000 description 1
- 210000004293 Mammary Glands, Human Anatomy 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000000214 Mouth Anatomy 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000003786 Myxedema Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036428 airway hyperreactivity Effects 0.000 description 1
- 201000000736 amenorrhea Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000954 anitussive Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000001174 ascending Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001709 ictal Effects 0.000 description 1
- 200000000018 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009613 pulmonary function test Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible Effects 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Abstract
The invention relates to the field of medicinal formulation, particularly relates to a traditional Chinese medicinal decoction for treating bronchial asthma, which is characterized in that the decoction is prepared from the following raw materials by weight percentage: ramie root 4-8%, reed root 5-8%, Rhizoma Cynanchi Stauntonii 5-8%, cassia twig 3-6%, Cornus officinalis fruit 5-8%, Atractylodes macrocephala 4-7%, Polygonatum odoratum 6-9%, Morus alba bark 6-9%, Brassica alba seed 4-6%, Terminalia chebula 5-7%, Tinospora sinensis 5-7%, Lagotis 3-5%, Kaempferia galangal 3-5%, Herba Ephedrae 2-5%, Astragalus membranaceus 3-6%, Herba Inulae 2-5%, Trichosanthes kirilowii 3-5% and corydalis tuber 5-8%, and is prepared by soaking the above raw materials in water, decocting, filtering to remove residues and collecting filtrate. The traditional Chinese medicinal decoction provided by the invention has low cost and no toxic and adverse side effects, has a good therapeutic effect on bronchial asthma, has effects of removing heat from the lung and dissolving phlegm and relieving asthma, and is suitable for asthma with deficiency and solid syndromes.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine decoction for the treatment of bronchial asthma.
Background technology
As everyone knows, bronchial asthma is respiratory system commonly encountered diseases, frequently-occurring disease, is the chronic airway inflammation disease being participated in by various kinds of cell and cellular component.This chronic inflammatory disease is relevant to airway hyperreactivity, causes that bronchial muscular spasm shrinks, vasodilation, and myxedema and secretion increase, and cause a kind of disease of Reversible airway obstruction.Clinical main manifestations is ictal expiratory dyspnea with wheezing sound, cough and expectoration, be everlasting night and outbreak aggravation in early morning.Bronchial asthma is as diagnosis and treatment not in time, with the prolongation of the course of disease, can produce air flue irreversibility constriction and Airway Remodeling, and severe patient is forced to take seat or is orthopnea, and cyanosis etc. even appears in dry cough or cough a large amount of white foam expectorant.Some teenager, its symptoms of asthma shows as when motion and occurs uncomfortable in chest, cough and dyspnea, is common clinical.Clinical treatment is mainly that the methods such as application hormone are controlled at present, and not only expense is high, and easily recurrence, to patient, has brought great economy and mental burden.
Summary of the invention
Technical problem to be solved by this invention is in order to overcome the deficiencies in the prior art, and a kind of Chinese medicine decoction for the treatment of bronchial asthma is provided, and cost is low, and treatment bronchial asthma curative effect is high, has no side effect, and is applicable to the asthma of deficiency and excess card.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine decoction for the treatment of bronchial asthma, it is characterized in that crude drug composition is by weight percentage, Radix Boehmeriae 4～8%, root of phragmites communis 5～8%, Rhizoma Cynanchi Stauntonii 5～8%, Ramulus Cinnamomi 3～6%, Fructus Corni 5～8%, the Rhizoma Atractylodis Macrocephalae 4～7%, Rhizoma Polygonati Odorati 6～9%, Cortex Mori 6～9%, Semen Sinapis Albae 4～6%, Fructus Chebulae 5～7%, Herba Lycopodii 5～7%, Radix Pecteilis susannae 3～5%, Rhizoma Kaempferiae 3～5%, Herba Ephedrae 2～5%, the Radix Astragali 3～6%, Herba Inulae 2～5%, Fructus Trichosanthis 3～5%, Rhizoma Corydalis 5～8%, by the medicinal water soaking of above-mentioned raw materials, the filtrate of removing slag after decocting to obtain.
The invention has the beneficial effects as follows, cost is low, and treatment bronchial asthma curative effect is high, has no side effect, and has removing heat from the lung and dissipating phlegm, and the function that dissipating fluid-retention only roars, should lung relieving asthma is applicable to the asthma of void and excess syndrome.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Adopting Radix Boehmeriae, root of phragmites communis, Rhizoma Cynanchi Stauntonii, Ramulus Cinnamomi, Fructus Corni, the Rhizoma Atractylodis Macrocephalae, Rhizoma Polygonati Odorati, Cortex Mori, Semen Sinapis Albae, Fructus Chebulae, Herba Lycopodii, Radix Pecteilis susannae, Rhizoma Kaempferiae, Herba Ephedrae, the Radix Astragali, Herba Inulae, Fructus Trichosanthis, Rhizoma Corydalis is that crude drug is prepared from.Every pair of its component (% by weight) is Radix Boehmeriae 6, root of phragmites communis 6, Rhizoma Cynanchi Stauntonii 7, Ramulus Cinnamomi 5, Fructus Corni 7, the Rhizoma Atractylodis Macrocephalae 6, Rhizoma Polygonati Odorati 8, Cortex Mori 8, Semen Sinapis Albae 5, Fructus Chebulae 6, Herba Lycopodii 7, Radix Pecteilis susannae 5, Rhizoma Kaempferiae 4, Herba Ephedrae 3, the Radix Astragali 4, Herba Inulae 3, Fructus Trichosanthis 4, Rhizoma Corydalis 6.Getting above-mentioned 18 taste crude drug gross weights is 180 grams, at room temperature 18 taste Chinese herbal medicine is added water to 900～1000ml left and right, soaks 4～6 hours, then boil with high heat slow fire and decoct to 80～90 minutes, the filtrate 150ml that removes slag to obtain, medicinal residues add water 200～300ml again, decoct 30～40 minutes, the filtrate 50ml that removes slag to obtain, to obtain 200ml left and right medicine juice altogether, makes decoction of the present invention, pack in aseptic vial, seal bottle cap is standby, and 1 dose minute every day 2 times is oral, each (medicine) being taken before meal 100ml.In the time of oral decoction of the present invention, then the cream that is boiled into of 120 grams of fit applications leaf fat, 120 grams of maltose, 120 gram of three taste of Mel, take every day 3 times, each serving 1 soupspoon, in mouthful containing changing.This kind of method fit applications 30 days is a course for the treatment of, interval 3～5 days, then carry out next course for the treatment of, 3 courses for the treatment of of general continuous use.After withdrawing, then take merely the cream one month that above-mentioned three tastes are boiled into, reach and activate lung meridian network, activate autoimmune system, completely the object of Control of asthma outbreak.
Radix Boehmeriae cooling blood for hemostasis of the present invention, clearing heat and preventing abortion, diuresis, removing toxic substances.Spitting of blood due to main bleeding due to blood-heat, spits blood, epistaxis, and stranguria with blood, has blood in stool, metrorrhagia, purpura, frequent fetal movement, vaginal bleeding during pregnancy hematochezia, dribbling urination; The effect of root of phragmites communis tool clearing away heat and promoting production of body fluid, preventing or arresting vomiting, relieving restlessness.Be usually used in that consumption of body fluid caused by febrile disease, dysphoria with smothery sensation are thirsty, the levying of the few Tianjin of dryness of the tongue, or gastric heat vomiting, cough due to lung-heat, expectorant are thick, the cough of xerostomia and affection due to external wind and heat; Rhizoma Cynanchi Stauntonii eliminating the pathogens from the lung sending down the abnormal ascending QI, lower expectorant antitussive.Control excess of the lung dyspnea with fullness of the chest, cough, excessive phlegm, gastralgia; Ramulus Cinnamomi diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation.Control exterior syndrome due to wind-cold, shoulder back of the body podomere ache, thoracic obstruction phlegm retention, amenorrhea and mass in the abdomen; Fructus Corni liver and kidney tonifying, restrains astringent or styptic treatment for spontaneous sweatingly, and controlling nocturnal emission with astringent drugs reducing urination leukorrhagia stopping only collapses, and hidroschesis also has promoting the production of body fluid to quench thirst in addition.Be used for, soreness of waist and knee joint dizziness and tinnitus, forgetful, seminal emission, spermatorrhea, enuresis frequent micturition, bleeding not during menses, menoxenia, profuse sweating collapse, interior-heat is quenched one's thirst; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive effect.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement; Rhizoma Polygonati Odorati nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid.Cough caused by dryness, chronic cough, the dry throat and mouth of the cloudy liquid consumption of calentura wound, interior-heat is quenched one's thirst, and deficiency of YIN diseases caused by exogenous pathogenic factor are dizzy dizzy, muscle arteries and veins spasm and pain; Cortex Mori eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema.For lung-heat cough with asthma, the edema of the face, the diseases such as dysuria; Semen Sinapis Albae warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral pain relieving, reduces phlegm by drink.Mass dissipating and swelling eliminating, main cough with asthma abundant expectoration, fullness in the chest and hypochondriac pain, numb limbs and tense tendons, arthralgia, multiple abscess caused by damp-phlegm, carbuncle of yin nature toxic swelling.Control acute mastitis, breast carcinoma, mammary gland pain, tuberculosis, phlegm retention cough with asthma, fullness and distention in the chest and hypochondrium pain, regurgitation vomiting, aphasia due to apoplexy, limbs arthralgia pain is numb, beriberi, carbuncle of yin nature, toxic swelling, treating swelling and pain by traumatic injury; Fructus Chebulae is bitter, sour, puckery, flat, returns lung, large intestine channel.Effect: astringing lung-QI and relieving cough, relieving diarrhea with astringents, relieving sore throat to recover voice.Application: be the common medicine of controlling chronic diarrhea chronic dysentery, the therapeutic method to keep the adverse QI flowing downwards cough-relieving of also astringing the lung, removing heat from the lung and relieving sorethroat sound producing, for controlling the key medicine of aphonia; Herba Lycopodii is for wind-expelling pain-stopping, relaxing muscles and tendons and activating QI and blood in the collateral.Cure mainly rheumatic arthralgia, lumbar muscle strain, traumatic injury; Radix Pecteilis susannae is controlled chronic consumptive disease and is spitted blood.Promoting the circulation of blood removing heat from blood, lung heat clearing fire.Control haematemesis, consumptive disease wound, lung abscess, consumptive lung disease, jaundice, distressed, traumatic injury, pathogenic wind, overstrain, cough spitting of blood, toxic swelling; Rhizoma Kaempferiae warming middle-JIAO, helps digestion, pain relieving.Control trusted subordinate's cold type of pain, stop dyspepsia, traumatic injury, toothache.For septum pectorale distension, coldness and pain in the epigastrium.Diet does not disappear.Herba Ephedrae has the effect of relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing, inducing diuresis to remove edema; Radix Astragali nature and flavor are sweet, tepor.Return lung, spleen, liver, kidney channel.There is the effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema.The ingenious prescription of 18 taste Chinese herbal medicine, drug effect mutual reinforcement between, the mutual-assistance, mutual restraint between two drugs compatibility, to strengthen the identical or approximate curative effect of medication of effect, improve principal agent effect, alleviates its toxic and side effects.To activate lung meridian network, activate autoimmune system, reach removing heat from the lung and dissipating phlegm, dissipating fluid-retention is only roared, and the effect of should lung relievining asthma, to control the object of bronchial asthma.
The embodiment that each raw material of the present invention also can the listed ratio of according to the form below (percentage by weight) mixes realizes.Its processing technique is identical with embodiment 1.
The clinical trial of carrying out below in conjunction with my institute is done further, is described in detail the present invention:
1, case selection: selected case is Bronchial Asthmas, male 24 examples, female's 26 examples; 17～72 years old age; According to the clinical asthma in acute attack state of an illness, be divided into slight 17 examples, moderate 22 examples, severe 11 examples, its diagnosis of 50 routine patients all meets the 7th edition diagnostic criteria of < < internal medicine > > of Lu Zaiying, Zhong Nanshan chief editor.
2, Therapeutic Method: 1 dose minute every day 2 times is oral, each (medicine) being taken before meal 100m1, in the time of oral decoction of the present invention, then the cream that is boiled into of 120 grams of fit applications leaf fat, 120 grams of maltose, 120 gram of three taste of Mel, takes 3 times every day, each serving 1 soupspoon, in mouthful containing changing.This kind of method fit applications 30 days was 1 course for the treatment of, interval 3～5 days, then carry out next course for the treatment of.3 courses for the treatment of of continuous application.After withdrawing, then take merely the cream one month that above-mentioned three tastes are boiled into.
3, curative effect judgement: effective: apply 3 courses for the treatment of, patient's asthma clinical symptoms sign all disappears, and activity is not limited, awake without suppressing night, without acute attack, normal pulmonary function.
Effective: apply 3 the course for the treatment of patient clinical symptom and sign partly disappear, occasionally have to suppress night and wake up and acute attack, run, even uncomfortable in chest, the cough that has that skelps, pulmonary function test is roughly normal;
Invalid: apply 3 courses for the treatment of, clinical symptoms sign and pulmonary function are without change.
4, therapeutic effect: use the present invention to treat 50 routine patients, carry out treatment effectiveness evaluation according to the standard of curative effect evaluation; Effective 26 examples, effective 17 examples, invalid 7 examples, total effective rate 86%.
Claims (1)
1. a Chinese medicine decoction for the treatment of bronchial asthma, it is characterized in that: crude drug composition is by weight percentage, Radix Boehmeriae 4～8%, root of phragmites communis 5～8%, Rhizoma Cynanchi Stauntonii 5～8%, Ramulus Cinnamomi 3～6%, Fructus Corni 5～8%, the Rhizoma Atractylodis Macrocephalae 4～7%, Rhizoma Polygonati Odorati 6～9%, Cortex Mori 6～9%, Semen Sinapis Albae 4～6%, Fructus Chebulae 5～7%, Herba Lycopodii 5～7%, Radix Pecteilis susannae 3～5%, Rhizoma Kaempferiae 3～5%, Herba Ephedrae 2～5%, the Radix Astragali 3～6%, Herba Inulae 2～5%, Fructus Trichosanthis 3～5%, Rhizoma Corydalis 5～8%, by the medicinal water soaking of above-mentioned raw materials, the filtrate of removing slag to obtain after decocting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410030619.7A CN103751674A (en) | 2014-01-15 | 2014-01-15 | Traditional Chinese medicinal decoction for treating bronchial asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410030619.7A CN103751674A (en) | 2014-01-15 | 2014-01-15 | Traditional Chinese medicinal decoction for treating bronchial asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103751674A true CN103751674A (en) | 2014-04-30 |
Family
ID=50519101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410030619.7A Pending CN103751674A (en) | 2014-01-15 | 2014-01-15 | Traditional Chinese medicinal decoction for treating bronchial asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103751674A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727038A (en) * | 2016-04-05 | 2016-07-06 | 吴京波 | Traditional Chinese medicine composition for treating bronchial asthma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432563A (en) * | 2013-09-11 | 2013-12-11 | 延安职业技术学院 | Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma |
-
2014
- 2014-01-15 CN CN201410030619.7A patent/CN103751674A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432563A (en) * | 2013-09-11 | 2013-12-11 | 延安职业技术学院 | Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma |
Non-Patent Citations (1)
| Title |
|---|
| 魏文浩: "姜良铎教授辨治哮证经验", 《河北中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727038A (en) * | 2016-04-05 | 2016-07-06 | 吴京波 | Traditional Chinese medicine composition for treating bronchial asthma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550517B (en) | A kind of medicine of Hepatoma therapy | |
| CN103623358B (en) | A kind of Chinese medicine decoction for the treatment of acute, chronic pharyngitis | |
| CN103071023B (en) | Traditional Chinese medicinal composition for effectively treating diabetes | |
| CN100594035C (en) | Chinese medicine compound oral administration for treating gastric ulcer | |
| CN102908606A (en) | Traditional Chinese medicine for treating pregnancy vomiting | |
| CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN103536881B (en) | A kind of medicine for the treatment of chronic gastritis | |
| CN103550696B (en) | Medicine for treating lung cancer | |
| CN103463566B (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN103751691B (en) | A kind of medicine for the treatment of eczema | |
| CN104367811A (en) | Traditional Chinese medicinal composition for treating neurasthenia | |
| CN101204481A (en) | Chinese traditional medicine for chronic nephritis | |
| CN103041213A (en) | Traditional Chinese medicine composition for soothing nerves, calming and relieving depression | |
| CN101036717B (en) | Orally taken type Chinese traditional medicine combination for curing irritable bowel syndrome | |
| CN104042766A (en) | Traditional Chinese medicinal composition for treating habitual constipation | |
| CN102091279B (en) | Traditional Chinese medicine composition for treating duodenal ulcer | |
| CN103800697A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
| CN103599430B (en) | A kind of Chinese medicine composition being used for the treatment of cardiac asthma | |
| CN103285294B (en) | Threatened abortion prevention and treatment traditional Chinese medicine, and preparation method thereof | |
| CN105106802A (en) | Traditional Chinese medicine composition for treating peripheral facial paralysis | |
| CN103751674A (en) | Traditional Chinese medicinal decoction for treating bronchial asthma | |
| CN101912502A (en) | Traditional Chinese medicine for treating acute urethrocystitis | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN102973886A (en) | Traditional Chinese medicine composition for treating chronic gastritis and enteritis | |
| CN103656459B (en) | A kind of Chinese medicine for the treatment of deficiency of both lung and spleen syndrome cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140430 |